Search - tctmd.com

Displaying 21 - 38 of 38

Sort: Relevancy | Date

News Daily News

Less Bivalirudin, Minimal Ultrasound: Survey Highlights Global Transradial Practice Patterns

Michael O'Riordan

November 28, 2018

News Conference News TCT 2018

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

Michael O'Riordan

September 24, 2018

News Conference News TCT 2018

Radial Access Doubled for Left Main PCI in the UK Between 2007 and 2014

Yael L. Maxwell

September 21, 2018

Increased Radial Access Is Not Associated With Worse Femoral Outcomes for PCI in UK

News Daily News

High-Volume Transradial PCI Centers Do Not Lose Femoral Skills: BCIS Registry

Michael O'Riordan

February 17, 2017

News Daily News

The Good, the Bad, and the Ugly: PCI Public Reporting Needs Fine-tuning, Says SCAI

Todd Neale

October 20, 2016

News Conference News VEITH 2015

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

Yael L. Maxwell

November 19, 2015

News Daily News

En Pacientes IAM, la Ventaja Precoz de Calidad de Vida de los SLF sobre los SMD Desaparece el cabo de 1 Año

Yael L. Maxwell

July 31, 2015

News Industry News

Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology

July 29, 2015

News Daily News

Resultados Tranquilizadores de un Registro sobre Aterectomía Rotacional Pre-PCI

Todd Neale

July 23, 2015

News Features

Drug-Coated Balloon Approvals Mark ‘Sea Change’ for Treatment of PAD

L.A. McKeown

January 28, 2015

News Daily News

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

May 30, 2014

News Daily News

Primer Estudio en Humanos ILLUMENATE: Un Nuevo Balón Recubierto de Fármacos Arroja Resultados Sólidos a los 2 Años en Lesiones de la Arteria Femoral Superficial

May 30, 2014

News Daily News

Large-Scale PCI Outcomes Study Shows Improvements Over Time in United States

August 02, 2013

News Daily News

Most Deaths Within 30 Days After PCI Not a Direct Result of Procedure

Caitlin E. Cox

May 13, 2013

News Daily News

Los Expertos Eligen los Avances Más Importantes de 2011

Jason Kahn

March 08, 2012

News Industry News

Boston Scientific Announces Launch of PROMUS Element™ Platinum Chromium Stent System in Japan

February 29, 2012

News Daily News

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

September 12, 2011

News Industry News

NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications

July 18, 2011

Advertisement

Less Bivalirudin, Minimal Ultrasound: Survey Highlights Global Transradial Practice Patterns

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

Radial Access Doubled for Left Main PCI in the UK Between 2007 and 2014

High-Volume Transradial PCI Centers Do Not Lose Femoral Skills: BCIS Registry

The Good, the Bad, and the Ugly: PCI Public Reporting Needs Fine-tuning, Says SCAI

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

En Pacientes IAM, la Ventaja Precoz de Calidad de Vida de los SLF sobre los SMD Desaparece el cabo de 1 Año

Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology

Resultados Tranquilizadores de un Registro sobre Aterectomía Rotacional Pre-PCI

Drug-Coated Balloon Approvals Mark ‘Sea Change’ for Treatment of PAD

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

Primer Estudio en Humanos ILLUMENATE: Un Nuevo Balón Recubierto de Fármacos Arroja Resultados Sólidos a los 2 Años en Lesiones de la Arteria Femoral Superficial

Large-Scale PCI Outcomes Study Shows Improvements Over Time in United States

Most Deaths Within 30 Days After PCI Not a Direct Result of Procedure

Los Expertos Eligen los Avances Más Importantes de 2011

Boston Scientific Announces Launch of PROMUS Element™ Platinum Chromium Stent System in Japan

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content